Skip to content
Chemcrux Enterprises logo

Chemcrux Enterprises

CHEMCRUX NSE
₹77.99 −1.38 (−1.74%)
P/E
27.85
View as Markdown
MCP
Close 4 Nov 2026 ₹77.99 −43.36 −35.7% 1Y
Start ₹121.35

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
6.43%
Debt to Equity
0.45
EPS (TTM)
₹2.80
Book Value
₹52.14
Market Cap
—
P/E (TTM)
27.85
P/B
1.50
ROE
3.01%
Dividend Yield
1.26%
EBITDA
₹13.20 Cr
52W High
₹135.60
52W Low
₹64.00
Day Range
₹77.28 – ₹79.94
Volume
3,305

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Chemcrux Enterprises peer comparison
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Chemcrux Enterprises (this company)
₹77.9927.85₹118 Cr1.501.26%3.01%6.43%₹86 Cr₹4 Cr
Median 8 companies₹1,559.5543.80₹20,474 Cr4.680.36%9.74%11.65%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

57 Good

Data confidence 98/100

Category scores

Quality
81
Strong
Returns, margins, earnings quality 22% weight
Valuation
49
Average
Cheap vs sector & own history 24% weight
Growth
67
Strong
Sales & profit trajectory 9% weight
Financial Health
42
Weak
Solvency, leverage, coverage 9% weight
Momentum
37
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 31.7%
  • Company's working capital requirements have reduced from 33.2 days to 16.2 days

Weaknesses

1
  • Company has a low return on equity of 6.46% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1270
OscillatorsBearish270
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
42.71
Neutral
MACD (12,26,9)
−0.55
Bearish
SMA (50)
81.44
Bearish
SMA (200)
88.42
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
3Y−5.36%
1Y+15.20%
TTM+24.03%

Net profit

Net profit growth by window
3Y−36.20%
1Y−4.60%
TTM+49.82%

Operating cash flow

Operating cash flow growth by window
3Y−2.23%
1Y+82.48%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
3Y−8.72 pp
1Y+0.65 pp
TTM+1.50 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹95.27 Cr
Mar 2023₹95.15 Cr
Mar 2024₹78.47 Cr
Mar 2025₹70.01 Cr
Mar 2026₹80.65 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹14.86 Cr
Mar 2023₹14.36 Cr
Mar 2024₹8.44 Cr
Mar 2025₹3.91 Cr
Mar 2026₹3.73 Cr

Quarterly Results

₹ Cr
540395 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
22.29
15.84
21.81
18.54
17.11
17.76
19.42
15.72
16.5
17.75
22.11
24.28
21.94
Expenses
18.43
13.5
17.43
15.92
15.05
15.4
16.73
13.61
14.87
15.96
18.58
20.1
19.24
Operating Profit
3.86
2.34
4.38
2.62
2.06
2.36
2.69
2.11
1.63
1.79
3.53
4.18
2.7
OPM %
17.32%
14.77%
20.08%
14.13%
12.04%
13.29%
13.85%
13.42%
9.88%
10.08%
15.97%
17.22%
12.31%
Other Income
0.18
0.24
0.56
0.35
0.39
0.26
0.61
0.24
0.44
0.63
0.6
0.36
0.11
Interest
0.31
0.21
0.17
0.13
0.13
0.33
0.6
0.69
0.86
0.83
0.76
0.7
0.64
Depreciation
0.57
0.58
0.58
0.55
0.56
0.73
0.92
0.99
1.18
1.2
1.19
1.17
1.18
PBT
3.16
1.79
4.19
2.29
1.76
1.56
1.78
0.67
0.03
0.39
2.18
2.67
0.99
Tax %
26.27%
30.17%
36.75%
3.49%
29.55%
26.28%
25.84%
68.66%
−233.33%
46.15%
27.98%
30.71%
48.48%
Net Profit
2.33
1.24
2.66
2.21
1.24
1.15
1.32
0.21
0.09
0.21
1.58
1.85
0.51
EPS (₹)
1.57
0.84
1.8
1.49
0.84
0.78
0.89
0.14
0.06
0.14
1.07
1.25
0.34

Profit & Loss

₹ Cr
540395 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
95.27
95.15
78.47
70.01
80.65
86.08
Expenses
74.56
73.69
65.1
60.78
69.5
73.88
Operating Profit
20.71
21.46
13.37
9.23
11.15
12.2
OPM %
21.74%
22.55%
17.04%
13.18%
13.83%
14.17%
Other Income
1
1.05
1.18
1.49
2.02
1.7
Interest
0.17
0.82
0.83
1.75
3.15
2.93
Depreciation
1.59
2.04
2.29
3.21
4.73
4.74
PBT
19.95
19.65
11.43
5.76
5.29
6.23
Tax %
25.51%
26.92%
26.16%
32.12%
29.3%
—
Net Profit
14.86
14.36
8.44
3.91
3.73
4.15
EPS (₹)
10.03
9.7
5.7
2.64
2.52
2.8
Div. Payout %
19.93%
20.63%
17.55%
37.88%
39.71%
—

Balance Sheet

₹ Cr
540395 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14.81
14.81
14.81
14.81
14.81
Reserves
39.87
51.6
57.45
59.81
62.04
Borrowings
9.75
14.43
26.46
42.3
34.37
Other Liabilities
19.34
12.38
11.15
10.13
16.22
Total Liabilities
83.77
93.22
110
127
127
Fixed Assets
25.49
33.11
33.09
77.06
74.96
CWIP
0
0.31
21.06
1.61
4.08
Investments
7.08
16.79
19.83
19.83
15.93
Other Assets
51.2
43.01
35.89
28.55
32.47
Total Assets
83.77
93.22
110
127
127

Cash Flow

₹ Cr
540395 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9.16
14.82
16.34
7.59
13.85
Investing
−2.64
−20.48
−25.89
−5.98
−0.07
Financing
3.96
0.96
7.64
−5.66
−12.36
Net Cash Flow
10.49
−4.7
−1.91
−4.04
1.42
Free Cash Flow
4.59
3.71
−6.85
−0.64
8.74
CFO/OP
69
86
142
98
136

Ratios

540395 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
72.33
51.56
71.17
61.42
85.58
Inventory Days
92.33
125
99.63
135
69.24
Days Payable
92.57
71.19
70.84
60.56
105
Cash Conversion Cycle
72.09
105
99.96
136
49.43
Working Capital Days
37.43
67.28
55.49
27.94
16.16
ROCE %
—
27.63%
13.46%
6.69%
6.43%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Chemcrux Enterprises insights

62 extracted metrics across FY17–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 72.92%
  • Public 25.81%
  • Others 1.27%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Chemcrux Enterprises

What does Chemcrux Enterprises Ltd do?
Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates
Where is Chemcrux Enterprises Ltd (CHEMCRUX) listed?
Chemcrux Enterprises Ltd trades as CHEMCRUX on the NSE and under code 540395 on the BSE.
Which sector does Chemcrux Enterprises Ltd belong to?
Chemcrux Enterprises Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Chemcrux Enterprises Ltd?
Chemcrux Enterprises Ltd trades at a PE ratio of 27.85 as of 4 Nov 2026, on earnings per share of ₹2.8, against a book value of ₹52.14 per share.
What is the 52-week high and low of Chemcrux Enterprises Ltd?
Over the last 52 weeks Chemcrux Enterprises Ltd has traded between ₹64 and ₹135.6 as of 4 Nov 2026.
Does Chemcrux Enterprises Ltd pay dividends?
Chemcrux Enterprises Ltd has a dividend yield of 1.26%.
What is the Return on Equity (ROE) of Chemcrux Enterprises Ltd?
Chemcrux Enterprises Ltd reported a return on equity of 3.01%. Its debt-to-equity ratio is 0.45.

Company Information

Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates

Website chemcrux.com
Listed 28 Mar 2017
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540395.md for Chemcrux Enterprises Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More